MTOR and fleck corneal dystrophy: Our single-cell genotyping strategy focused on GoF variants in two well-established FCD2 genes, PIK3CA and MTOR, could be applied at a larger scale in future studies to address the potentially different impact of specific genes and variants in FCD, and help generate more effective, targeted pharmacological treatments.